The PSA bounce Does it have clinical significance?
...ith external-beam radiation in the U.S., radiation oncologists have examined the "PSA bounce" phenomenon and dete...rostate cancer. Urologists, radiation and medical oncologists have struggled with what a bouncing PSA means for a patient's prognosis, and how or if to offer furt...The Molecular Profiling Institute named US provider of genetic breast cancer test
...tion this test may provide valuable assistance for oncologists in formulating tailor-made treatment plans. Approx..." prognosis or "poor" prognosis. The results allow oncologists to implement a more effective and personalized treatment plan. Typically, oncologists use several cl...Doctors link common chemotherapy drug to jawbone necrosis
...atch and Novartis alerts issued in late September, oncologists and dentists were advised of the addition of osteonecrosis of the jaw to the "Precautions" and "Adverse Reactions" sections on the labeling of injectable bisphosphonates, describing the spontaneous reports of the condition being found mostly in cance...Next-era targeted therapy overcoming Gleevec's shortcomings
...ation between preclinical researchers and clinical oncologists is seamless," Giles says. "I don't work in a lab. I spend all my time with patients. But clinicians are now using molecular endpoints every day and in every way to direct our therapy and to design protocols. It is incredibly exciting."...The Molecular Profiling Institute, Inc. launches MammaPrint for breast cancer patients
...ditional therapy from those who would not, helping oncologists offer more effective therapy to their patients. P...enome Project and include many of the top clinical oncologists in the country. The MammaPrint test is now widely available through MPI, the sole provider of Mam...Check colon tumors for signs of syndrome, study suggests
...t to prescreen for Lynch syndrome should also help oncologists give patients more accurate information about their prognosis and five-year survival," Hampel says....Data confirm panitumumab single-agent antitumor activity in patients with mCRC
...t panitumumab may provide an additional avenue for oncologists to manage the disease." Patients in the study (n=148) were previously treated with 5FU (with or without leucovorin) and either irinotecan or oxaliplatin, or both. Patients received 2.5 mg/kg of panitumumab by weekly one-hour intravenous infusion with...Researchers find potential Celebrex target in lung cancer
...s and may be a target for Celebrex therapy, giving oncologists another weapon to fight cancer, according to a study by researchers at UCLA's Jonsson Cancer Center. Researchers found that PGE2, which is produced normally by epithelial cells but at very high levels in lung cancer and other malignancies, up-regul...Customized gene chip provides rapid detection of genetic changes in children's cancer
...ome more widely available as a diagnostic tool for oncologists treating patients with neuroblastoma, and possibly for other cancers. In addition to Drs. Maris, Fortina, and Surrey, other co-authors are George Hii, Peter S. White, Ph.D., and Eric Rappaport, Ph.D., of The Children's Hospital of Philadelphia; and C...Scientists discover genetic pathway responsible for breast cancer cell growth
...lead investigator Dr. Vincent Gigure. "This is how oncologists came to use anti-estrogen as drugs to combat the most common forms of breast cancer." What has remained a mystery however, is the molecular mechanism by which estrogen makes breast cancer cells grow. "Until this is solved, we will be no closer to fig...Rate of gain, obesity factor into increased risk for prostate cancer recurrence
...r recurrence of prostate cancer. "Urologists and oncologists can use this information when a man is diagnosed with prostate cancer to develop treatment strategies for that patient," Strom said. "By plugging in the clinical characteristics, they calculate each patient's risk of having more aggressive disease th...New imaging method shows early in treatment if brain cancer therapy is effective
...functional diffusion mapping will eventually allow oncologists to manage each patient's treatment based on real time evaluation of cellular response to therapy," says study author Suresh Mukherji, M.D., professor of radiology and otolaryngology and division director of neuroradiology at the U-M Medical School. T...ECCO 13 - One voice, one vision needed to overcome cancer in Europe
...sion. In addition, the possible future shortage of oncologists will make things even more complex. This feeling was re-iterated at ECCO 13 by Professor Mike Richards, National Cancer Director at St Thomas's Hospital, UK who said, "Assigning priorities to the delivery of medical care in general and, given the ra......iously benefited, from Iressa treatment. However, oncologists believe that Iressa still holds promise and contin...harmaceuticals and lead author of the study. When oncologists are able to distinguish between predictive and prognostic factors, they are better equipped to provi...Deleted genes help predict outcome in a children's cancer
...phia and other pediatric cancer centers. Pediatric oncologists have known for some time that amplification, an abnormal increase in the number of copies, of a cancer-causing gene called MYCN heralds a high-risk, aggressive form of neuroblastoma. However, some 60 percent of high-risk neuroblastoma tumors do not s...Tumor cells that border normal tissue are told to leave
...g out of the edges and dying," Cagan says. "But as oncologists have found, cancer stems from an accumulation of genetic mutations. If one of these wandering cells acquires a second mutation that prevents cell death, it could go on to establish a metastatic tumor." Having created a model for studying metastasis ...ESMO International Symposium on Prostate Cancer
...attend the meetings. To address the needs of both oncologists and scientists for multidisciplinary organ-based and mission-driven conferences, the ESMO International Symposium (EIS) Working Group was established. The EIS Working Group is responsible for the creation of a well-balanced and comprehensive scientif...Studies examine associations between provider characteristics and mortality rates in ovarian cancer
...on. Ovarian cancer patients treated by gynecologic oncologists had the best outcomes and lowest mortality rates a... patients treated by general surgeons. Gynecologic oncologists were most likely to perform sufficiently extensive surgery, and were most likely to provide patients...2006 SGO Annual Meeting on Women's Cancer
...on oncologists, pathologists and gynecologic nurse oncologists from all over the country. Attendees present and discuss the latest research findings in the field of gynecologic oncology that help to inform practice and care. More than 400 studies will be presented at the meeting -- all abstracts being presen...International scientists, physicians assemble at AACR Annual Meeting to discuss latest advances
...flow of information shared amongst researchers and oncologists at the AACR Annual Meeting has never played a greater role in advancing the field." This year's Annual Meeting will focus on new and promising therapeutic approaches for the prevention and treatment of cancer, and will highlight data from all stages ...